Steroids and bronchodilators for acute bronchiolitis in the first two years of life: Systematic review and meta-analysis

BMJ

Volumn 342, Issue 7801, 2011, Pages

  Hartling, Lisa ^a   Fernandes, Ricardo M ^b   Bialy, Liza ^a   Milne, Andrea ^a   Johnson, David ^c,d   Plint, Amy ^e   Klassen, Terry P ^f   Vandermeer, Ben ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b HOSPITAL DE SANTA MARIA   (Portugal)

^c INSTITUTO DE MEDICINA MOLECULAR JOÃO LOBO ANTUNES   (Portugal)

^d UNIVERSITY OF CALGARY   (Canada)

^e UNIVERSITY OF OTTAWA   (Canada)

^f UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; BRONCHODILATING AGENT; DEXAMETHASONE; IPRATROPIUM BROMIDE; PLACEBO; SALBUTAMOL; STEROID; TERBUTALINE;

ACUTE DISEASE; BRONCHIOLITIS; CHILD; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; EMBASE; HUMAN; INCIDENCE; LENGTH OF STAY; MEDLINE; META ANALYSIS; OUTPATIENT CARE; PATIENT CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; WHEEZING; AMBULATORY CARE; DRUG COMBINATION; HOSPITALIZATION; INFANT;

AMBULATORY CARE; BRONCHIOLITIS; BRONCHODILATOR AGENTS; DRUG THERAPY, COMBINATION; HOSPITALIZATION; HUMANS; INFANT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STEROIDS;

EID: 79953869340     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.d1714     Document Type: Review

References (50)

1. Wright AL, Taussig LM, Ray CG, Harrison HR, Holberg CJ. The Tucson Children's Respiratory Study: II. Lower respiratory tract illness in the first year of life. Am J Epidemiol 1989;129:1232-46. (Pubitemid 19148464)
2. Hall CB, Weinberg GA, Iwane MK, Blumkin AK, Edwards KM, Staat MA, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009;360:588-98.
3. Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet 2010;375:1545-55.
4. Viswanathan M, KingVJ, Bordley C, Honeycutt AA, Wittenborn J, Jackman AM, et al. Management of bronchiolitis in infants and children. Evid Rep Technol Assess (Summ) 2003;69:1-5.
5. Smyth R, Openshaw P. Bronchiolitis. Lancet 2006;368:312-22. (Pubitemid 44067248)
6. Babl FE, Sheriff N, Neutze J, Borland M, Oakley E. Bronchiolitis management in pediatric emergency departments in Australia and New Zealand: a PREDICT study. Pediatr Emerg Care 2008;24:656-8.
7. Plint AC, Johnson DW, Wiebe N, Bulloch B, Pusic M, Joubert G, et al. Practice variation among pediatric emergency departments in the treatment of bronchiolitis. Acad Emerg Med 2004;11:353-60. (Pubitemid 38437010)
8. Christakis DA, Cowan CA, Garrison MM, Molteni R, Marcuse E, Zerr DM. Variation in inpatients diagnostic testing and management of bronchiolitis. Pediatrics 2005;115:878-84.
9. Barben J, Kuehni CE, Trachsel D, HammerJ: Swill Paediatric Respiratory Research Group. Management of acute bronchiolitis: can evidence based guidelines alter clinical practice? Thorax 2008;63:1103-9.
10. Bialy L, Smith M, Bourke T, Becker L. The Cochrane Library and bronchiolitis: an umbrella review. Evid Based Child Health 2006;1:939-47.
11. American Academy of Pediatrics. Diagnosis and management of bronchiolitis. Pediatrics 2006;118:1774-93.
12. Scottish Intercollegiate Guidelines Network (SIGN). Bronchiolitis in children. A national clinical guideline. Report No 91. SIGN, 2006.
13. Turner T, Wilkinson F, Harris C, Mazza D: Health for Kids Guideline Development Group. Evidence based guideline for the management of bronchiolitis. Aust Fam Physician 2008;37:6-13.
14. Muething S, Schoettker PJ, Gerhardt WE, Atherton HD, Britto MT, Kotagal UR. Decreasing overuse of therapies in the treatment of bronchiolitis by incorporating evidence at the point of care. J Pediatr 2004;144:703-10. (Pubitemid 38858084)
15. Touzet S, Refabert L, Letrilliart L, Ortolan B, Colin C. Impact of consensus development conference guidelines on a primary care of bronchiolitis: are national guidelines beingfollowed?J Eval Clin Pract 2007;13:651-6. (Pubitemid 47240829)
16. Plint AC, Johnson DW, Patel H, Wiebe N, Correll R, Brant R, et al. Epinephrine and dexamethasone in children with bronchiolitis. N Engl J Med 2009;360:2079-89.
17. Corneli HM, Zorc JJ, Mahajan P, Shaw KN, Holubkov R, Reeves SD, et al. Amulticenter, randomized, controlled trial ofdexamethasone for bronchiolitis. N Engl J Med 2007;357:331-9. (Pubitemid 47124133)
18. Shojania KG, Sampson M, Ansari MT, Doucette S, Moher D. How quickly do systematic reviews go out of date? A survival analysis. Ann Intern Med 2007;147:224-33. (Pubitemid 351664578)
19. Schuh S, Coates AL, Binnie R, Allin T, Goia C, Corey M, et al. Efficacy of oral dexamethasone in outpatients with acute bronchiolitis. J Pediatr 2002;140:27-32. (Pubitemid 34117463)
20. Ioannidis JPA. Integration of evidence from multiple meta-analyses: a primer on umbrella reviews, treatment networks and multiple treatments meta-analyses. Can Med Assoc J 2009;181:488-93.
21. Caldwell DM, Ades AE, Higgins JPT. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. BMJ 2005;331:897-900. (Pubitemid 41502718)
22. Higgins JPT, Green S, eds. The Cochrane handbook for systematic reviews of interventions. The Cochrane Collaboration, 2008.
23. Owens DK, Lohr KN, Atkins D, Treadwell JR, Reston JT, Bass EB, et al. Grading the strength of a body of evidence when comparing medical interventions: Agency for Healthcare Research and Quality and the Effective Health Care Program. JClinEpidemiol2010;63:513-23.
24. Schünemann H, Brozek J, Oxman A, eds. GRADE handbook for gradingqualityofevidence and strength ofrecommendation. Version 3.2. The GRADE Working Group, 2009.
25. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88. (Pubitemid 17189972)
26. Higgins JP, Thompson SG. Quantifyingheterogeneityin a metaanalysis. Stat Med 2002;21:1539-58.
27. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60. (Pubitemid 37088507)
28. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med 2004;23:3105-24. (Pubitemid 39334902)
29. Higgins JP, Whitehead A. Borrowing strength from external trials in a meta-analysis. Stat Med 1996;15:2733-49. (Pubitemid 27011054)
30. Smith TC, Spiegelhalter DJ, Thomas A. Bayesian approaches to random-effects meta-analysis: a comparative study. StatMed 1995;14:2685-99. (Pubitemid 26014258)
31. Dias S, Welton NJ, Caldwell DM, Ades AE. Checking consistency in mixed treatment comparison. Stat Med 2010;29:932-44.
32. Glasziou PP, Shepperd S, Brassey J. Can we rely on the best trial? A comparison of individual trials and systematic reviews. BMC Med Res Methodol 2010;10:23.
33. Hartling L, Wiebe N, Russell K, Patel H, Klassen TP. Epinephrine for bronchiolitis. Cochrane Database Syst Rev 2004;1:CD003123.
34. Scarfone RJ. Controversies in the treatment of bronchiolitis. Curr Opin Pediatr 2005;17:62-6.
35. Wohl MEB, ChernickV. State of the art: bronchiolitis. Am RevRespir Dis 1978;118:759-81.
36. Openshaw PJ. Antiviral immune responses and lung inflammation after respiratory syncytial virus infection. Proc Am Thorac Soc 2005;2:121-5. (Pubitemid 41233378)
37. Thomas LH, Sharland M, Friedland JS. Steroids fail to down-regulate respiratory syncytial virus-induced IL-8 secretion in infants. Pediatr Res 2002;52:368-72. (Pubitemid 34920266)
38. Giembycz MA, Kaur M, Leigh R, Newton R. A Holy Grail of asthma management: toward understanding how long-acting beta(2)-adrenoceptor agonists enhance the clinical efficacyofinhaled corticosteroids. Br J Pharmacol 2008;153:1090-104. (Pubitemid 351415494)
39. Black JL, Oliver BG, Roth M. Molecular mechanisms of combination therapy with inhaled corticosteroids and long-acting beta-agonists. Chest2009;136:1095- 100.
40. Frey U, von Mutius E. The challenge of managingwheezing in infants. N Engl J Med 2009;360:2130-3.
41. Bush A. Practice imperfect - treatment for wheezing in preschoolers. N Engl J Med 2009;360:409-10.
42. Zhang L, Sanguebsche LS. The safety of nebulization with 3 to 5 ml of adrenaline (1:1000) in children: an evidence based review. J Pediatr (Rio J) 2005;81:193-7. (Pubitemid 41717632)
43. Halliday HL, Ehrenkranz RA, Doyle LW. Early (< 8 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Cochrane Database Syst Rev 2010;1:CD001146.
44. Onland W, De Jaegere AP, Offringa M, van Kaam AH. Effects ofhigher versus lower dexamethasone doses on pulmonaryand neurodevelopmental sequelae in preterm infants at risk for chronic lung disease: a meta-analysis. Pediatrics 2008;122:92-101.
45. Karemaker R, Kavelaars A, Wolbeek M, Tersteeg-Kamperman M, Baerts W, Veen S, et al. Neonatal dexamethasone treatment for chronic lung disease of prematurity alters the hypothalamuspituitary-adrenal axis and immune system activity at school age. Pediatrics 2008;121:e870-8.
46. Wilson-Costello D, Walsh MC, Langer JC, Guillet R, Laptook AR, Stoll BJ, et al. Impact of postnatal corticosteroid use on neurodevelopment at 18 to 22 months' adjusted age: effects of dose, timing, and risk of bronchopulmonary dysplasia in extremely low birth weight infants. Pediatrics 2009;123:e430-7.
47. Karemaker R, Karemaker JM, Kavelaars A, Tersteeg-Kamperman M, Baerts W, Veen S, et al. Effects ofneonatal dexamethasone treatment on the cardiovascular stress response of children at school age. Pediatrics 2008;122:978-87.
48. Flores G, Horwitz RI. Efficacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics 1997;100:233-9. (Pubitemid 27328202)
49. King VJ, Viswanathan M, Bordley WC, Jackma AM, Sutton SF, Lohr KN, et al. Pharmacologic treatment ofbronchiolitis in infants and children: a systematic review. Arch Pediatr Adolesc Med 2004;158:127-37. (Pubitemid 38173966)
50. Barbi E, Neri E, Ventura A. Nomina sunt consequentia rerum: time for a change in the definition of bronchiolitis? Arch Pediatr Adolesc Med 2004;158:403. (Pubitemid 38451573)